» Articles » PMID: 11823088

Doppler Myocardial Imaging to Evaluate the Effectiveness of Pacing Sites in Patients Receiving Biventricular Pacing

Overview
Date 2002 Feb 2
PMID 11823088
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The goal of this study was to compare the efficacy of biventricular pacing (BIV) at the most delayed wall of the left ventricle (LV) and at other LV walls.

Background: Biventricular pacing could provide additional benefit when it is applied at the most delayed site.

Methods: In 31 patients with advanced nonischemic heart failure, the activation delay was defined, in blind before BIV, by regional noninvasive Tissue Doppler Imaging as the time interval between the end of the A-wave (C point) and the beginning of the E-wave (O point) from the basal level of each wall. The left pacing site was considered concordant with the most delayed site when the lead was inserted at the wall with the greatest regional interval between C and O points (CO(R)). After BIV, patients were divided into group A (13/31) (i.e., paced at the most delayed site) and group B (18/31) (i.e., paced at any other site).

Results: After BIV, in all patients LV end-diastolic (LVEDV) and end-systolic (LVESV) volumes decreased (p = 0.025 and 0.001), LV ejection fraction (LVEF) increased (p = 0.002), QRS narrowed (p = 0.000), New York Heart Association class decreased (p = 0.006), 6-min walked distance (WD) increased (p = 0.046), the interval between closure and opening of mitral valve (CO) and isovolumic contraction time (ICT) decreased (p = 0.001 and 0.000), diastolic time (EA) and Q-P(2) interval increased (p = 0.003 and 0.000), while Q-A(2) interval and mean performance index (MPI) did not change. Group A showed greater improvement over group B in LVESV (p = 0.04), LVEF (p = 0.04), bicycle stress testing work (p = 0.03) and time (p = 0.08) capacity, CO (p = 0.04) and ICT (p = 0.02).

Conclusions: After BIV, LV performance improved significantly in all patients; however, the greatest improvement was found in patients paced at the most delayed site.

Citing Articles

Minute ventilation sensor-driven rate response as a part of cardiac resynchronization therapy optimization in older patients.

Karvonen J, Lehto S, Lenz C, Beaudoint C, Oyeniran S, Kayser T J Interv Card Electrophysiol. 2024; 67(9):2017-2027.

PMID: 38914900 PMC: 11711142. DOI: 10.1007/s10840-024-01848-1.


Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial.

Leclercq C, Burri H, Delnoy P, Rinaldi C, Sperzel J, Calo L Europace. 2023; 25(10).

PMID: 37776313 PMC: 10561537. DOI: 10.1093/europace/euad294.


The role of CT in arrhythmia management-treatment planning and post-procedural imaging surveillance.

Cundari G, Alkadhi H, Eberhard M Br J Radiol. 2023; 96(1151):20230028.

PMID: 37191058 PMC: 10607403. DOI: 10.1259/bjr.20230028.


Cardiac Resynchronization Therapy and Left Atrial Remodeling: A Novel Insight?.

Radu A, Zlibut A, Scarlatescu A, Cojocaru C, Bogdan S, Scafa-Udriste A Biomedicines. 2023; 11(4).

PMID: 37189774 PMC: 10136256. DOI: 10.3390/biomedicines11041156.


The role of guidance in delivering cardiac resynchronization therapy: A systematic review and network meta-analysis.

Mehta V, Ayis S, Elliott M, Widjesuriya N, Kardaman N, Gould J Heart Rhythm O2. 2022; 3(5):482-492.

PMID: 36340494 PMC: 9626880. DOI: 10.1016/j.hroo.2022.07.005.